Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
12 hasil
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This study followed WHO recommendations for in vivo antimalarial efficacy trials.
The study population comprised children aged 6 to 59 months with microscopically confirmed acute uncomplicated malaria. Other inclusion criteria included body weight ≥5kg, the presence of fever (≥37.5°C axillary) or a
TES Artemether-lumefantrine for Pf and Chloroquine (CQ) for Pv
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
1. BACKGROUND In 2002, the Philippines changed its antimalarial drug policy to the combination treatment, CQ+ Sulphadoxine-pyrimethamine (SP) as 1st-line treatment and artemether-lumefantrine as 2nd-line treatment. The Department of Health (DOH) prescribed the use of artemether-lumefantrine (AL)
Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Combination therapy, the new strategy for malaria treatment, is based on the hypothesis that two (or more) components of different mechanisms of action protect each other from development of resistance. Artemisinin as well as its two derivatives, e.g. artemether and artesunate, constitute a family
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Malaria incidence has increased two- to three-folds over the past four decades, and nearly half the world's population now lives in regions endemic for malaria: In Asia, Africa, and South America. A global annual estimate of 300-500 clinical cases of malaria and mortality in the range of 1-2 million
P. Falciparum Resistance to Artemisinin in Vietnam
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
3.1 Study Design This study is designed as a randomized open label 42-day follow-up study to evaluate the clinical and parasitological responses after treatment of uncomplicated P.falciparum infections with either AS or DHA-PPQ. Symptomatic patients with P.falciparum mono-infections, fulfilling the
Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
3.1 Study Design This study is designed as a 42-day drug efficacy study to evaluate clinical and parasitological responses after treatment of P.vivax malaria infections. Symptomatic patients with P. vivax mono-infections, meeting the study criteria, will be enrolled into the study, and treated with
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This study followed WHO recommendations for in vivo antimalarial efficacy trials.
The study population comprised children aged 6 to 59 months with microscopically confirmed acute uncomplicated malaria. Other inclusion criteria included body weight ≥5kg, the presence of fever (≥37.5°C axillary) or a
Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Background Plasmodium falciparum causes malaria and approximately 665 000 deaths each year. Previously chloroquine (CQ) and sulphadoxine-pyrimethamine were the principle drugs for the treatment of malaria. Due to widespread resistance to these drugs1, the World Health Organization recommends that P.
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Primary objective:
To assess the level of resistance to artemisinin derivatives in Western Cambodia.
Secondary objective:
To assess the level of resistance to other antimalarial drugs in Western Cambodia
1. Background; There are worrying signs from Western Cambodia that parasitological responses to
Kilimanjaro IPTi Drug Options Trial
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
1. Study design
The overall study design is a randomised trial of four treatment regimes in two different transmission settings. The four treatment regimes are as follows: (1) placebo, (2) mefloquine; (3) Lapdap; (4) SP. All medications will be given at the time of immunisation with DPT/polio 2,
A Trial of Antimalarial Drugs Used in Pregnancy in Tanzania
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The objectives of this study are to assess the therapeutic efficacy and safety of SP as the current first line drug, and three other potential alternative combinations in treating uncomplicated falciparum malaria during pregnancy, in an area with appreciable levels of SP resistance and rising HIV
Prevention of Severe Anaemia in Gambian Children
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Objectives
1. To assess the effectiveness of monthly prophylaxis with S/P on haematological recovery in children who have been treated for severe anaemia.
2. To measure compliance with the intervention
3. To investigate whether or not infection with chloroquine and S/P resistant strains contributes
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
